On Monday December 11th, the PROMoTeR Center will have a job talk featuring Dr. Fred Tabung at 1pm - 2pm in Inui A/B. He will be presenting on "The Inflammatory and Insulinemic Potential of Diet and Risk of Cancer".
On Monday December 4th, the PROMoTeR Center had a job talk featuring Dr. Nilah Ioannidis. She presented on "Clinical interpretation of genetic variation: Statistical methods and application to cutaneous squamous cell carcinoma".
PROMoTeR Center group presented their work to the Department
Christine Lu was invited to give a presentation, titled “A Model for Accelerating Evidence Generation for Genomic Technologies in the Context of a Learning Health Care System” at the "Implementing and Evaluating Genomic Screening Programs in Health Care Systems – A Workshop", National Academies of Sciences, Engineering and Medicine in Washington DC, November 1, 2017.
Christine Lu was invited as the Chair and a panelist of a session entitled, “Value based frameworks for precision medicine,” at the Evidence Pricing & Market Access World Congress, Philadelphia, PA, October 10-11, 2017.
Christine Lu was invited as part of a panel session “Putting the G in genome: Financial sustainability of genomic medicine” at the Festival of Genomics, Boston, MA, 3-4 October, 2017.
On Monday September 25th, the PROMoTeR Center will had a job talk featuring Dr. Sharon Lutz. She presented on "Approaches to Incorporate and Understand the Path from Gene to Disease."
Congratulations to Ann Wu, MD MPH (Principal Investigator), Chris Lu, MSc PhD, and Natasha Stout, PhD, on receiving an R01 funded by the National Institute of Child, Health, and Human Development. In the grant, the Precision Medicine Treatment (PreEMT) Model, Dr. Wu and HPHC co-investigators, will develop a computer model capable of simulating short- and long-term clinical benefits and estimating the cost-effectiveness of integrating different genome screening strategies into clinical care for healthy or high-risk newborns for a wide variety of heritable conditions. With this model, they will synthesize the best available clinical, epidemiologic, and economic data on genetic variants present at birth for a wide variety of genetically-driven childhood conditions to project health outcomes, and provide a dynamic tool to evaluate evolving knowledge in the area of genomics and precision medicine in the United States over the next decade.
Christine Lu and colleagues published an article in Genetics in Medicine entitled, "A proposed approach to accelerate evidence generation for genomic-based technologies in the context of a learning health system." The paper has been featured by the Centers for Disease Control and Prevention, Genomics and Health Impact Blog.
Ann Wu organized a workshop to create "An Official Research Statement of the ATS and NHLBI: Current Status and Future Directions in Lung Precision Medicine Research." Dr. Wu is pictured with patient speaker, Maki Inada, a non-smoker, who beat non small cell lung cancer with the help of precision medicine.
Esteban Burchard, MD MPH, advisor on President Obama's Precision Medicine Initiative working group, visited with the PROMoTeR Center.
Ann Wu participated in a Radcliffe Institute Seminar on Redesigning Health Systems for Precision Medicine.
Peter Kraft, Professor of Epidemiology at the Harvard School of Public Health, visited with members of the PROMoTeR Center.
Faculty from the PROMoTeR Center (Ann Wu, Christine Lu, and Maryam Asgari) attend the Harvard Medical School Leadership Development Course for Physicians and Scientists.
Christine Lu was invited to give a presentation, titled “Genomic Medicine: Access, Coverage and Ethics” at the National Academies of Sciences, Engineering and Medicine (formerly Institute of Medicine) in March in Washington DC.